Target intelligence / Profile preview

Bicarbonate transporter protein (NBCe1)

Target
NBCe1
Molecular classification
Transporter, Solute carrier family (SLC), Ion transporter, Anion exchanger (AE family for Cl⁻/HCO₃⁻ exchangers)
01

Overview

The bicarbonate transporter protein family includes multiple membrane-bound transporters (notably the SLC4 family) that mediate the movement of bicarbonate and associated ions (mainly sodium and chloride) across cell membranes. Their main physiological roles involve regulation of intracellular and extracellular pH, acid-base balance, and participation in processes like bicarbonate secretion/absorption in kidneys and various tissues. The SLC4 family consists of both sodium-dependent cotransporters (such as NBCe1, encoded by SLC4A4) and anion exchangers (such as AE1), with tissue-specific distribution including kidney, pancreas, nervous system, and eye. Defects in these proteins are implicated in several inherited and acquired human diseases, especially renal tubular acidosis, corneal dystrophy, and some neurological disorders. For structured, target-specific data, refer to family members such as Electrogenic sodium bicarbonate cotransporter 1 (NBCe1; SLC4A4) and Sodium bicarbonate transporter-like protein 11 (SLC4A11; BTR1) for gene- and disease-specific annotations.

Other names
Sodium bicarbonate cotransporterNBCNBCe1AESLC4A4SLC4A5SLC4A11BTR1CDPD1CHED2NABC1
02

Mechanism of action

Inhibitors: Bind to and block transporter function, affecting intracellular/extracellular pH and bicarbonate transport. Indirect modulators: Affect associated carbonic anhydrase interaction and alter rate of HCO₃⁻ movement or conversion.

03

Biological functions

Intracellular pH regulationBicarbonate secretion and absorptionAcid-base homeostasisCarbon dioxide/bicarbonate transportSignal transduction (for some regulatory SLC4 family proteins)
04

Disease associations

Renal tubular acidosis (NBCe1 defects)Glaucoma and corneal dystrophy (SLC4A11/BTR1 mutations)Familial hemiplegic migraine (SLC4A4 mutations)Neurological disorders (brain pH regulation)Other metabolic disorders
05

Safety considerations

Disturbances in acid-base balance (risk of systemic or tissue acidosis/alkalosis)Ocular toxicity (for SLC4A11-related interventions)Neurological effects with transporter inhibitors
06

Interacting drugs

Acetazolamide

1 more in the full profile.

07

Biomarkers

Mutations in SLC4A4 (NBCe1) for renal or neurologic disease diagnosisSLC4A11 (for corneal dystrophy risk)Urinary or plasma bicarbonate and pH levels

Beyond the preview

Go deeper on Bicarbonate transporter protein (NBCe1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bicarbonate transporter protein (NBCe1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call